K940-1907 Screening compound: N-[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]-2-(4-{[(4-ETHOXYPHENYL)CARBAMOYL]METHYL}PIPERAZIN-1-YL)ACETAMIDE

K940-1907 Screening compound: N-[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]-2-(4-{[(4-ETHOXYPHENYL)CARBAMOYL]METHYL}PIPERAZIN-1-YL)ACETAMIDE
K940-1907 Screening compound: N-[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]-2-(4-{[(4-ETHOXYPHENYL)CARBAMOYL]METHYL}PIPERAZIN-1-YL)ACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K940-1907
N-[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]-2-(4-{[(4-ETHOXYPHENYL)CARBAMOYL]METHYL}PIPERAZIN-1-YL)ACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K940-1907

Molecular Formula

C23H26ClF3N4O3 (C23 H26 ClF3 N4 O3)

Compound Name

N-[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]-2-(4-{[(4-ETHOXYPHENYL)CARBAMOYL]METHYL}PIPERAZIN-1-YL)ACETAMIDE

IUPAC name

n/a

SMILES

CCOc(cc1)ccc1NC(CN1CCN(CC(Nc(cc2)cc(C(F)(F)F)c2Cl)=O)CC1)=O

InChI

InChI=1S/C23H26ClF3N4O3/c1-2-34-18-6-3-16(4-7-18)28-21(32)14-30-9-11-31(12-10-30)15-22(33)29-17-5-8-20(24)19(13-17)23(25,26)27/h3-8,13H,2,9-12,14-15H2,1H3,(H,28,32)(H,29,33)

InChI Key

IVYFMXZYAAXQEV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15115181

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

498.93

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.043

Distribution Coefficient, logD

4.999

Water Solubility, LogSw

-5.13

Polar Surface Area

60.934

Acid Dissociation Constant (pKa)

8.38

Base Dissociation Constant (pKb)

4.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.00

K940-1907 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

CNS targets activity set (6557 compounds)

Immunological Library (6760 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Immune system
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
  • Kinases

References: we are preparing a list of scientific research reports with K940-1907 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K940-1907?
Check Price and Availability of K940-1907, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K940-1907 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K940-1907
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K940-1907
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K940-1907 available by request